Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Primary Biliary Cholangitis (PBC): later-stage trial registry

1 of 1 indexed Primary Biliary Cholangitis (PBC) trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Primary Biliary Cholangitis (PBC): 1 US clinical trial tracked, 1 recruiting.

Primary Biliary Cholangitis (PBC) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ipsen, running 1 of these trials.

Enrollment posture brief

Registry condition primary-biliary-cholangitis-pbc

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Primary Biliary Cholangi (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis (PBC) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Primary Biliary Cholangitis (PBC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Primary Biliary Cholangitis (PBC) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Ipsen 1 trials

Named interventions

Most-linked intervention names on Primary Biliary Cholangitis (PBC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Matched 80 mg placebo Other
1 trials
Elafibranor Drug
1 trials

US sites by state

Facility locations filed on Primary Biliary Cholangitis (PBC) trials. A trial with sites in several states counts in each.

New York 1 trials
New Mexico 1 trials
Michigan 1 trials
Louisiana 1 trials
Kansas 1 trials
Florida 1 trials
Colorado 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Primary Biliary Cholangitis (PBC) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Primary Biliary Cholangitis (PBC) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Ipsen sponsors the most Primary Biliary Cholangitis (PBC) trials on record, review their full trial history before evaluating a specific study. See Ipsen's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Primary Biliary Cholangitis (PBC) condition card totals 1 registered trials; most-linked intervention Matched 80 mg placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.